» Articles » PMID: 27242973

Surface Proteins and Pneumolysin of Encapsulated and Nonencapsulated Streptococcus Pneumoniae Mediate Virulence in a Chinchilla Model of Otitis Media

Overview
Date 2016 Jun 1
PMID 27242973
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Streptococcus pneumoniae infections result in a range of human diseases and are responsible for almost one million deaths annually. Pneumococcal disease is mediated in part through surface structures and an anti-phagocytic capsule. Recent studies have shown that nonencapsulated S. pneumoniae (NESp) make up a significant portion of the pneumococcal population and are able to cause disease. NESp lack some common surface proteins expressed by encapsulated pneumococci, but express surface proteins unique to NESp. A chinchilla model of otitis media (OM) was used to determine the effect various pneumococcal mutations have on pathogenesis in both NESp and encapsulated pneumococci. Epithelial cell adhesion and invasion assays were used to examine the effects in relation to deletion of intrinsic genes or expression of novel genes. A mouse model of colonization was also utilized for comparison of various pneumococcal mutants. It was determined that pneumococcal surface protein K (PspK) and pneumolysin (Ply) affect NESp middle ear pathogenesis, but only PspK affected epithelial cell adhesion. Experiments in an OM model were done with encapsulated strains testing the importance of native virulence factors and treatment of OM. First, a triple deletion of the common virulence factors PspA, PspC, and Ply, (ΔPAC), from an encapsulated background abolished virulence in an OM model while a PspC mutant had detectable, but reduced amounts of recoverable bacteria compared to wildtype. Next, treatment of OM was effective when starting antibiotic treatment within 24 h with resolution by 48 h post-treatment. Expression of NESp-specific virulence factor PspK in an encapsulated strain has not been previously studied, and we showed significantly increased adhesion and invasion of human epithelial cells by pneumococci. Murine colonization was not significantly increased when an encapsulated strain expressed PspK, but colonization was increased when a capsule mutant expressed PspK. The ability of PspK expression to increase colonization in a capsule mutant despite no increase in adhesion can be attributed to other functions of PspK, such as sIgA binding or immune modulation. OM is a substantial economic burden, thus a better understanding of both encapsulated pneumococcal pathogenesis and the emerging pathogen NESp is necessary for effective prevention and treatment.

Citing Articles

The Yin and Yang of Pneumolysin During Pneumococcal Infection.

Pereira J, Xu S, Leong J, Sousa S Front Immunol. 2022; 13:878244.

PMID: 35529870 PMC: 9074694. DOI: 10.3389/fimmu.2022.878244.


A Novel Pneumococcal Surface Protein K of Nonencapsulated Promotes Transmission among Littermates in an Infant Mouse Model with Influenza A Virus Coinfection.

Sakatani H, Kono M, Nanushaj D, Murakami D, Takeda S, Kaneko F Infect Immun. 2022; 90(2):e0062221.

PMID: 34978928 PMC: 8853673. DOI: 10.1128/iai.00622-21.


Oxidative killing of encapsulated and nonencapsulated Streptococcus pneumoniae by lactoperoxidase-generated hypothiocyanite.

Gingerich A, Doja F, Thomason R, Toth E, Bradshaw J, Douglass M PLoS One. 2020; 15(7):e0236389.

PMID: 32730276 PMC: 7392276. DOI: 10.1371/journal.pone.0236389.


Pneumolysin: Pathogenesis and Therapeutic Target.

Nishimoto A, Rosch J, Tuomanen E Front Microbiol. 2020; 11:1543.

PMID: 32714314 PMC: 7343714. DOI: 10.3389/fmicb.2020.01543.


Morin inhibits Listeria monocytogenes virulence in vivo and in vitro by targeting listeriolysin O and inflammation.

Li G, Wang G, Li M, Li L, Liu H, Sun M BMC Microbiol. 2020; 20(1):112.

PMID: 32398085 PMC: 7216731. DOI: 10.1186/s12866-020-01807-6.


References
1.
Mitchell A, Mitchell T . Streptococcus pneumoniae: virulence factors and variation. Clin Microbiol Infect. 2010; 16(5):411-8. DOI: 10.1111/j.1469-0691.2010.03183.x. View

2.
Joloba M, Windau A, Bajaksouzian S, Appelbaum P, Hausdorff W, Jacobs M . Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis. 2001; 33(9):1489-94. DOI: 10.1086/323027. View

3.
Magee A, Yother J . Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun. 2001; 69(6):3755-61. PMC: 98386. DOI: 10.1128/IAI.69.6.3755-3761.2001. View

4.
Thornton J, Durick-Eder K, Tuomanen E . Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage. J Mol Med (Berl). 2010; 88(2):103-7. PMC: 2864529. DOI: 10.1007/s00109-009-0578-5. View

5.
AVERY O, Macleod C, McCarty M . STUDIES ON THE CHEMICAL NATURE OF THE SUBSTANCE INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES : INDUCTION OF TRANSFORMATION BY A DESOXYRIBONUCLEIC ACID FRACTION ISOLATED FROM PNEUMOCOCCUS TYPE III. J Exp Med. 2009; 79(2):137-58. PMC: 2135445. DOI: 10.1084/jem.79.2.137. View